37 results Philippe Campolini Partner Brussels Leen De Vuyst Counsel Brussels Anna Collignon Partner Amsterdam Louis Bidaine Associate Brussels Ignace Vernimme Partner Brussels Tom Barkhuysen Partner Amsterdam Tom Barkhuysen Partner Amsterdam Vince Van der Wangen Junior Associate Brussels Pascal Vanden Borre Partner Brussels Frederik Vandendriessche Partner Brussels Nathanaelle Kiekens Partner Brussels Jan Truijens Martinez Counsel Amsterdam Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review. Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin. Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products. FAQ: Wat houdt het Wetsvoorstel elektronische gegevensuitwisseling in de zorg (Wegiz) in en wat is de verhouding tot de AVG? (Digitale) gegevensuitwisseling in de zorg is een actueel thema. Illustratief is een item bij EenVandaag van april 2021 waarin de analoge werkwijze bij gegevensuitwisseling in de zorg wordt aangekaart. Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs). Dutch Council of State cross-border decision: Minister rightly imposed fines on Curacao-based online platform for medicinal products In the summer of 2021, the Dutch Council of State ruled that the Curacao-based company responsible for the website Dokteronline.com had rightly received two administrative fines. Pagination Current page 1 Page 2 Page 3 Next page
Stibbe authors the Belgian chapter of the Pharmaceutical IP and Competition Law Review Philippe Campolini, Sophie Van Besien, Ignace Vernimme and Peter Wytinck authored the Belgian Chapter of the Pharmaceutical Intellectual Property and Competition Law Review.
Ignace Vernimme and Philippe Campolini authored the article “Covid-19: the Belgian perspective” Ignace Vernimme and Philippe Campolini contributed to the 2020 edition of the IBA Healthcare and Life Sciences Law Committee e-bulletin.
Breaking news from the CJEU: no SPCs for new therapeutic applications On 9 July 2020, the Grand Chamber of the CJEU ruled on the interpretation of Article 3(d) of Regulation 469/2009 concerning the supplementary protection certificate (CCP) for medicinal products.
FAQ: Wat houdt het Wetsvoorstel elektronische gegevensuitwisseling in de zorg (Wegiz) in en wat is de verhouding tot de AVG? (Digitale) gegevensuitwisseling in de zorg is een actueel thema. Illustratief is een item bij EenVandaag van april 2021 waarin de analoge werkwijze bij gegevensuitwisseling in de zorg wordt aangekaart.
Discover our SPC booklet Our Brussels IP/Life Sciences team has authored a booklet on the case-law of the Court of justice of the EU (CJEU) regarding supplementary protection certificates (SPCs).
Dutch Council of State cross-border decision: Minister rightly imposed fines on Curacao-based online platform for medicinal products In the summer of 2021, the Dutch Council of State ruled that the Curacao-based company responsible for the website Dokteronline.com had rightly received two administrative fines.